In 2014, Martin Shkreli earned $537.50K in total compensation at Travere Therapeutics, Inc., including $237.50K salary and $300.00K bonus. Led Travere Therapeutics, Inc. as CEO for 3 years.
Compensation History
Annual executive compensation data for Martin Shkreli, including salary, bonuses, and stock awards.
Year
2014
Total Compensation
$537.50K
Salary
$237.50K
Bonus
$300.00K
Other
$0.00
Salary
$237.50KBoard Justification
In accordance with the terms of the Shkreli Employment Agreement, Mr. Shkreli was paid (i) a base salary in the amount of $300,000, and (ii) at the sole discretion of the Board of Directors, an annual bonus award based upon specific goals and performance metrics.
Bonus
$300.00KBoard Justification
Mr. Shkreli received a base salary of $237,500 and a bonus of $300,000 for fiscal 2014.
Other Compensation
$0.00Board Justification
Amount shown represents severance payments to Mr. Shkreli.
Restricted Stock
Board Justification
Not applicable
Performance Metrics
at the sole discretion of the Board of Directors, an annual bonus award based upon specific goals and performance metrics.
Martin Shkreli
Founder and Ex-CEO of Travere Therapeutics, Inc.
Education
B.S. in Business Administration from Baruch College
Field of Expertise
Healthcare & Life Sciences - Pharmaceuticals
Sector of Economy
Healthcare
Born
April 1, 1983 - 42 years ago
CEO of Travere Therapeutics, Inc. for
3 years 7 months (Feb 2011 - Sep 2014)
Previous Experience
Founder of Retrophin, Inc.
Other Travere Therapeutics, Inc. CEOs
Holdings
Track Martin Shkreli's stock holdings and portfolio value over time.
Insider Trading
Martin Shkreli's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Martin Shkreli with competitor CEOs and industry peers.